title: Effects of CERA (continuous erythropoietin receptor activator) in patients with advanced non-small-cell lung cancer (NSCLC) receiving chemotherapy: results of a phase II study.
authors.affiliation: Division of Medical Oncology, Hospital Clinic Provincial, Barcelona, Spain.
authors.forename: P
authors.initials: P
authors.lastname: Gascon
authors.affiliation: Department of Medicine I, Medical University of Vienna, Vienna, Austria.
authors.forename: R
authors.initials: R
authors.lastname: Pirker
authors.affiliation: Department of Medical Oncology, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Del Mastro
authors.affiliation: Clinical Science-Anemia, Hoffmann-La Roche Ltd, Basel, Switzerland. Electronic address: laurence.durrwell@roche.com.
authors.forename: L
authors.initials: L
authors.lastname: Durrwell